Literature DB >> 9126902

Clonality of multiple meningiomas.

A P Stangl1, R Wellenreuther, D Lenartz, J A Kraus, A G Menon, J Schramm, O D Wiestler, A von Deimling.   

Abstract

A significant number of patients with meningiomas develop multiple tumors without anatomical bridges. To understand the mechanism by which multiple meningiomas arise, the authors analyzed DNA from 39 multiple meningiomas in 12 patients to locate alterations in the neurofibromatosis type 2 (NF2) gene. This gene has been shown to be inactivated in meningiomas. No patient in our series had a family history of meningiomas or NF2. All tumors were investigated by single-strand conformation polymorphism analysis of the entire coding region of the NF2 gene and by direct DNA sequencing of altered fragments. The DNA from meningiomas in 10 patients carried NF2 gene mutations. In six of the 10 patients with NF2 mutations, all tumors in the respective individual exhibited the identical DNA alteration in the NF2 gene, thus indicating clonal origin. All four patients with more than two lesions had clonal meningiomas and four patients with two meningiomas each carried different mutations in their tumors. Analysis of constitutional DNA revealed a wild-type NF2 sequence in all 12 patients, thus excluding a forme fruste of NF2 in these cases. Our data demonstrate that the majority of multiple meningiomas with NF2 gene mutations are of somatic and clonal origin. Spread of tumor cells via the cerebrospinal fluid is the most likely mechanism to account for the development of these multiple meningiomas.

Entities:  

Mesh:

Year:  1997        PMID: 9126902     DOI: 10.3171/jns.1997.86.5.0853

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

Authors:  L B Jacoby; D Jones; K Davis; D Kronn; M P Short; J Gusella; M MacCollin
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

Review 4.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

5.  Paediatric supra- and infratentorial multiple giant clear cell meningioma: A report of a rare case and review of the literature.

Authors:  Xuanyu Tan; Yubo Wang; Wei Jiang; Yue Cao; Yongliang Teng; Gang Zhao
Journal:  Childs Nerv Syst       Date:  2020-11-20       Impact factor: 1.475

6.  Meningiomatosis restricted to the left cerebral hemisphere with acute clinical deterioration: Case presentation and discussion of treatment options.

Authors:  Victoria Ohla; Christian Scheiwe
Journal:  Surg Neurol Int       Date:  2015-04-20

7.  Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.

Authors:  MariaDolores Tabernero; María Jara-Acevedo; Ana B Nieto; Arancha Rodríguez Caballero; Alvaro Otero; Pablo Sousa; Jesús Gonçalves; Patricia H Domingues; Alberto Orfao
Journal:  BMC Med Genet       Date:  2013-10-30       Impact factor: 2.103

8.  Somatic SMARCB1 Mutation in Sporadic Multiple Meningiomas: Case Report.

Authors:  Alice S Wang; Ali O Jamshidi; Nathan Oh; Ronald Sahyouni; Behdokht Nowroozizadeh; Ronald Kim; Frank P K Hsu; Daniela Bota
Journal:  Front Neurol       Date:  2018-10-26       Impact factor: 4.003

9.  Multiple meningiomas arising within the same hemisphere associated with Li-Fraumeni syndrome.

Authors:  Christopher S Hong; E Zeynep Erson-Omay; Jennifer Moliterno
Journal:  Surg Neurol Int       Date:  2021-03-17

10.  Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.

Authors:  Yiping Shen; Fabio Nunes; Anat Stemmer-Rachamimov; Marianne James; Gayatry Mohapatra; Scott Plotkin; Rebecca A Betensky; David A Engler; Jennifer Roy; Vijaya Ramesh; James F Gusella
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.